CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Guangdong Hybribio Biotech Co Ltd Company Snapshot
Guangdong Hybribio Biotech Co Ltd operates within the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Guangdong Hybribio Biotech Co Ltd with three other companies in this sector in CHINA : Beijing Strong Biotechnologies Inc (2019 sales of 840.86 million Chinese Renmimbi [US$120.55 million] of which 100% was Medical Treatment and Public Health), Getein Biotech Inc (968.20 million Chinese Renmimbi [US$138.81 million] of which 80% was In-vitro diagnostics), and Beijing Leadman Biochemistry Co Ltd (515.14 million Chinese Renmimbi [US$73.86 million] of which 97% was Biological and Pharmaceutical Products).

Sales Analysis. During the year ended December of 2019, sales at Guangdong Hybribio Biotech Co Ltd were 729.39 million Chinese Renmimbi (US$104.57 million). This is an increase of 25.7% versus 2018, when the company's sales were 580.35 million Chinese Renmimbi. This was the fifth consecutive year of sales increases at Guangdong Hybribio Biotech Co Ltd (and since 2014, sales have increased a total of 176%). Sales of Medical Testing Servicee saw an increase that was more than double the company's growth rate: sales were up 69.3% in 2019, from 56.41 million Chinese Renmimbi to 95.52 million Chinese Renmimbi.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Guangdong Hybribio Biotech Co Ltd
  Stock Performance Chart for Guangdong Hybribio Biotech Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (7/31/2020): 51.59
(Figures in Chinese Renmimbi)
1 Week 3.5%   13 Weeks 2.9%  
4 Weeks 67.8%   52 Weeks 263.8%  
 
Guangdong Hybribio Biotech Co Ltd Key Data:
  Ticker: 300639 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2019 Sales 729,392,802
(Year Ending Jan 2020).
Employees: 1,340
  Currency: Chinese Renmimbi Market Cap: 10,960,516,512
  Fiscal Yr Ends: December Shares Outstanding: 212,454,284
  Share Type: A GU Closely Held Shares:
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.